Muhammad Nazmul Hasan

9PUBLICATIONS
9CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Cellular interactions (incl. adhesion, matrix, cell wall)Chemical and thermal processes in energy and combustionMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 23, 2026
Nintedanib inhibits the VEGFR-ERK signaling pathway in human KRAS-mutated cancer cells.

|Mar 01, 2026
Targeting fatty acid synthase suppresses tumor development in NF2/CDKN2A-deficient pleural mesothelioma.

Sivasundaram Karnan, Akinobu Ota, Muhammad Nazmul Hasan

|Jan 28, 2024
ARK5 enhances cell survival associated with mitochondrial morphological dynamics from fusion to fission in human multiple myeloma cells.

Sivasundaram Karnan, Ichiro Hanamura, Akinobu Ota

|Nov 27, 2023
Leucine zipper protein 1 (LUZP1) regulates the constriction velocity of the contractile ring during cytokinesis.

Toshinori Hyodo, Eri Asano-Inami, Satoko Ito

|Nov 09, 2023
Flow cytometry-based quantification of genome editing efficiency in human cell lines using the L1CAM gene.

Muhammad Nazmul Hasan, Toshinori Hyodo, Mrityunjoy Biswas

|Jul 21, 2023
CAMK2D: a novel molecular target for BAP1-deficient malignant mesothelioma.

Sivasundaram Karnan, Akinobu Ota, Hideki Murakami

Pageof 2

Frequent Collaborators

7 joint publications

Akinobu Ota

7 joint publications

Hiroyuki Konishi

4 joint publications

Sivasundaram Karnan

4 joint publications

Md Wahiduzzaman